These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 10962093
1. Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence. Wang EJ, Casciano CN, Clement RP, Johnson WW. Biochim Biophys Acta; 2000 Aug 31; 1481(1):63-74. PubMed ID: 10962093 [Abstract] [Full Text] [Related]
2. Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet. Qu Q, Sharom FJ. Biochemistry; 2002 Apr 09; 41(14):4744-52. PubMed ID: 11926837 [Abstract] [Full Text] [Related]
3. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model. Garrigos M, Mir LM, Orlowski S. Eur J Biochem; 1997 Mar 01; 244(2):664-73. PubMed ID: 9119038 [Abstract] [Full Text] [Related]
4. Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs. Li MJ, Nath A, Atkins WM. Biochemistry; 2017 May 16; 56(19):2506-2517. PubMed ID: 28441502 [Abstract] [Full Text] [Related]
5. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein. Shapiro AB, Ling V. Eur J Biochem; 1998 May 15; 254(1):189-93. PubMed ID: 9652413 [Abstract] [Full Text] [Related]
6. P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer. Shapiro AB, Corder AB, Ling V. Eur J Biochem; 1997 Nov 15; 250(1):115-21. PubMed ID: 9431998 [Abstract] [Full Text] [Related]
7. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. Romsicki Y, Sharom FJ. Biochemistry; 2001 Jun 12; 40(23):6937-47. PubMed ID: 11389609 [Abstract] [Full Text] [Related]
8. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Shapiro AB, Ling V. Eur J Biochem; 1997 Nov 15; 250(1):130-7. PubMed ID: 9432000 [Abstract] [Full Text] [Related]
9. Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1). Chufan EE, Kapoor K, Sim HM, Singh S, Talele TT, Durell SR, Ambudkar SV. PLoS One; 2013 Nov 15; 8(12):e82463. PubMed ID: 24349290 [Abstract] [Full Text] [Related]
10. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. Shapiro AB, Fox K, Lam P, Ling V. Eur J Biochem; 1999 Feb 15; 259(3):841-50. PubMed ID: 10092872 [Abstract] [Full Text] [Related]
11. Communication between multiple drug binding sites on P-glycoprotein. Martin C, Berridge G, Higgins CF, Mistry P, Charlton P, Callaghan R. Mol Pharmacol; 2000 Sep 15; 58(3):624-32. PubMed ID: 10953057 [Abstract] [Full Text] [Related]
12. Transport of LDS-751 from the cytoplasmic leaflet of the plasma membrane by the rhodamine-123-selective site of P-glycoprotein. Shapiro AB, Ling V. Eur J Biochem; 1998 May 15; 254(1):181-8. PubMed ID: 9652412 [Abstract] [Full Text] [Related]
13. Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Wang EJ, Casciano CN, Clement RP, Johnson WW. Pharm Res; 2003 Apr 15; 20(4):537-44. PubMed ID: 12739759 [Abstract] [Full Text] [Related]
14. Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3. Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport. Schlemmer SR, Sirotnak FM. J Biol Chem; 1994 Dec 09; 269(49):31059-66. PubMed ID: 7983045 [Abstract] [Full Text] [Related]
15. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Pascaud C, Garrigos M, Orlowski S. Biochem J; 1998 Jul 15; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975 [Abstract] [Full Text] [Related]
16. Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis. Martin C, Berridge G, Mistry P, Higgins C, Charlton P, Callaghan R. Biochemistry; 2000 Oct 03; 39(39):11901-6. PubMed ID: 11009602 [Abstract] [Full Text] [Related]
17. Uncoupled active transport mechanisms accounting for low selectivity in multidrug carriers: P-glycoprotein and SMR antiporters. Krupka RM. J Membr Biol; 1999 Nov 15; 172(2):129-43. PubMed ID: 10556361 [Abstract] [Full Text] [Related]
18. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium. Swed A, Eyal S, Madar I, Zohar-Kontante H, Weiss L, Hoffman A. Mol Pharm; 2009 Nov 15; 6(6):1883-90. PubMed ID: 19722701 [Abstract] [Full Text] [Related]
19. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system. Ramachandra M, Ambudkar SV, Gottesman MM, Pastan I, Hrycyna CA. Mol Biol Cell; 1996 Oct 15; 7(10):1485-98. PubMed ID: 8898356 [Abstract] [Full Text] [Related]
20. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation. Sharom FJ, Lu P, Liu R, Yu X. Biochem J; 1998 Aug 01; 333 ( Pt 3)(Pt 3):621-30. PubMed ID: 9677321 [Abstract] [Full Text] [Related] Page: [Next] [New Search]